DK3586837T3 - Sammensætninger omfattende aminosyrer til anvendelse ved forebyggelse og behandling af leversygdomme - Google Patents

Sammensætninger omfattende aminosyrer til anvendelse ved forebyggelse og behandling af leversygdomme Download PDF

Info

Publication number
DK3586837T3
DK3586837T3 DK19166892.0T DK19166892T DK3586837T3 DK 3586837 T3 DK3586837 T3 DK 3586837T3 DK 19166892 T DK19166892 T DK 19166892T DK 3586837 T3 DK3586837 T3 DK 3586837T3
Authority
DK
Denmark
Prior art keywords
prevention
compositions
treatment
amino acids
liver diseases
Prior art date
Application number
DK19166892.0T
Other languages
English (en)
Inventor
Paolo Luca Maria Giorgetti
Original Assignee
Professional Dietetics Int S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Dietetics Int S R L filed Critical Professional Dietetics Int S R L
Application granted granted Critical
Publication of DK3586837T3 publication Critical patent/DK3586837T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK19166892.0T 2018-06-27 2019-04-02 Sammensætninger omfattende aminosyrer til anvendelse ved forebyggelse og behandling af leversygdomme DK3586837T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102018000006725A IT201800006725A1 (it) 2018-06-27 2018-06-27 Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche

Publications (1)

Publication Number Publication Date
DK3586837T3 true DK3586837T3 (da) 2021-03-01

Family

ID=63491976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19166892.0T DK3586837T3 (da) 2018-06-27 2019-04-02 Sammensætninger omfattende aminosyrer til anvendelse ved forebyggelse og behandling af leversygdomme

Country Status (22)

Country Link
US (1) US20210260011A1 (da)
EP (1) EP3586837B1 (da)
JP (1) JP7347744B2 (da)
KR (1) KR20210025611A (da)
CN (1) CN112334129A (da)
AU (1) AU2019293293A1 (da)
BR (1) BR112020026431A2 (da)
CA (1) CA3104839A1 (da)
CL (1) CL2020003209A1 (da)
CY (1) CY1124030T1 (da)
DK (1) DK3586837T3 (da)
EA (1) EA202092749A1 (da)
ES (1) ES2858355T3 (da)
IT (1) IT201800006725A1 (da)
LT (1) LT3586837T (da)
MX (1) MX2020013471A (da)
PH (1) PH12020552254A1 (da)
PL (1) PL3586837T3 (da)
RS (1) RS61613B1 (da)
SG (1) SG11202012297XA (da)
WO (1) WO2020003013A1 (da)
ZA (1) ZA202007834B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700087376A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT201700087359A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
WO2022266480A1 (en) * 2021-06-17 2022-12-22 Axcella Health Inc. Methods of predicting liver fat content and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049818A1 (ja) * 2005-10-27 2007-05-03 Ajinomoto Co., Inc. 抗脂肪肝、抗肥満及び抗高脂血症用組成物
JP2007161642A (ja) 2005-12-14 2007-06-28 Kyowa Hakko Kogyo Co Ltd アルコール性肝障害抑制剤
US20130084378A1 (en) * 2011-09-30 2013-04-04 Daesang Corporation Amino acid seasoning compositions comprising l-glutamic acid and l-lysine
US9597367B2 (en) * 2013-04-19 2017-03-21 Bioventures, Llc Methods for improving muscle and heart function
EP3231437B1 (en) 2014-12-09 2020-02-05 Nihon Sizen Hakkoh Co., Ltd. Aging inhibitor
US20180161296A1 (en) * 2015-05-11 2018-06-14 Newcastle Innovation Limited Amino acid supplementation

Also Published As

Publication number Publication date
JP2021529731A (ja) 2021-11-04
WO2020003013A1 (en) 2020-01-02
EA202092749A1 (ru) 2021-06-23
PH12020552254A1 (en) 2021-08-16
ZA202007834B (en) 2021-10-27
EP3586837A1 (en) 2020-01-01
EP3586837B1 (en) 2020-12-23
RS61613B1 (sr) 2021-04-29
CL2020003209A1 (es) 2021-06-04
ES2858355T3 (es) 2021-09-30
IT201800006725A1 (it) 2019-12-27
JP7347744B2 (ja) 2023-09-20
US20210260011A1 (en) 2021-08-26
PL3586837T3 (pl) 2021-09-13
MX2020013471A (es) 2021-02-18
KR20210025611A (ko) 2021-03-09
CN112334129A (zh) 2021-02-05
BR112020026431A2 (pt) 2021-03-30
SG11202012297XA (en) 2021-01-28
LT3586837T (lt) 2021-05-10
CA3104839A1 (en) 2020-01-02
CY1124030T1 (el) 2022-05-27
AU2019293293A1 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
IL284371B (en) Amino acid compounds and methods for treating liver diseases
DK3586837T3 (da) Sammensætninger omfattende aminosyrer til anvendelse ved forebyggelse og behandling af leversygdomme
DK3658132T3 (da) Sammensætninger omfattende aminosyrer til anvendelse ved behandling af mitokondrielle dysfunktion-relaterede sygdomme
DK3402499T3 (da) Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes
IL286592B (en) Amino acid compounds for the treatment of liver disease
DK3790879T3 (da) Triazolopyrimidinforbindelser og deres anvendelse til behandling af kræft
DK3860990T3 (da) Inhibitorer for YAP/TAZ-TEAD interaktion og disses anvendelse ved behandlingen af cancer
IL282251A (en) Compositions and methods for treatment of liver disease
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3773615T3 (da) Flydende sammensætning til anvendelse ved behandling af slimhinden i munden-svælget-struben-spiserøret
DK3373922T3 (da) Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri
DK3810128T3 (da) Sammensætninger til behandling og/eller forebyggelse af proteinaggregeringssygdomme
DK3937948T3 (da) Phytoecdysoner og derivater deraf til anvendelse i behandlingen af neuromuskulære sygdomme
DK3515409T3 (da) Kompleks og sammensætninger til behandling af oftalmologiske og dermatologiske sygdomme
DK3658133T3 (da) Sammensætninger omfattende aminosyrer til anvendelse ved behandling af fedme
DK3898981T3 (da) Fremgangsmåder og sammensætninger til behandling af glykogenlagringssygdomme
DK3429616T3 (da) Sammensætninger til behandlingen og forebyggelse af hov- og klovsygdomme
DK3752253T3 (da) Sammensætning til forebyggelse og behandling af hårvækstforstyrrelser
DK3612174T3 (da) Fremgangsmåder og farmaceutiske sammensætninger til behandlingen af sygdomme associeret med reduceret cftr-funktion
DK3621941T3 (da) Anvendelse af precursorer til fremstilling af carbon-11-mærkede aminosyrer og derivater deraf
DK3484476T3 (da) Meclozin-derivater til anvendelse ved forebyggelse og/eller behandling af lidelser associeret med den forårsagede inflammation
ZA201706986B (en) Compositions for the treatment of kidney and/or liver disease
DK3383381T3 (da) Forbindelse til anvendelse til forebyggelse og behandling af neurodegenerative sygdomme
DK3072509T3 (da) Sammensætninger til behandling af mortellaros sygdom og fremgangsmåder til fremstilling deraf
DK3796897T3 (da) Sammensætninger til forebyggelse og behandling af hud- eller slimhindesygdomme med en betændelseskomponent